Proposals to drop race questions from the 2030 census and end EEOC workforce reporting could leave gaps in national racial data.
|Podcasts|April 25, 2023
Health Equity Conversations: Barriers to Equitable Care
Author(s)Matthew Gavidia
On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.
Advertisement
AJMC.com recently launched a resource center, the
On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion (DEI) advancing health equity in their respective organization’s policy and practice initiatives, including:
- Joneigh Khaldun, MD, MPH, FACEP, vice president and chief health equity officer for CVS Health
- Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health
- Kirk Campbell, MD, FASN, vice chair for DEI in the Department of Medicine at Mount Sinai Health System in New York
Advertisement
Related to this article
Experts at GOLD 2026 say targeted case finding, AI, and guideline-based treatment can close COPD’s diagnostic gap and improve patient outcomes.
In this Q&A, Rob Stransky of NiceRx explains how to screen patients for gray-market retatrutide use and why cost drives demand for unregulated peptides.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.
In this Q&A, Christie Ballantyne, MD, explains why consistent LDL-C lowering with oral enlicitide could expand PCSK9 use in primary prevention.
Real-world study tracks JAK inhibitors in alopecia areata and atopic dermatitis, flagging menstrual alterations and weight gain as key safety signals.
SGLT2 inhibitors were linked to hemoglobin gains of about 1.0 to 1.6 g/dL in small MDS and MPN studies, but a review found no randomized trials to confirm.
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
3
The Liver Meeting 2026 Highlights Hepatitis Delta, PBC Targets, MASH Costs
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5